ESRA/ASRA儿童区域麻醉局麻药及佐剂剂量建议
欧洲区域麻醉与疼痛治疗学会(ESRA)和美国区域麻醉与疼痛医学学会(ASRA)联合组建委员会,基于系统文献检索和专家意见制定儿童区域麻醉局麻药及佐剂剂量实践建议。建议包括:新生儿和婴儿脊麻布比卡因1 mg/kg、大于1岁儿童0.5 mg/kg;0.5%丁卡因脊麻剂量0.07-0.13 mL/kg;超声引导上肢外周神经阻滞布比卡因或罗哌卡因0.5-1.5 mg/kg;右美托咪定可作佐剂延长阻滞时间。目前缺乏高级别证据指导儿童区域阻滞局麻药剂量。
要点
- 新生儿和婴儿脊麻布比卡因剂量1 mg/kg,大于1岁儿童0.5 mg/kg。
- 0.5%丁卡因用于脊麻推荐剂量0.07-0.13 mL/kg。
- 超声引导上肢外周神经阻滞布比卡因或罗哌卡因0.5-1.5 mg/kg。
核心结论
- 目前尚无高级别证据指导儿童区域阻滞局麻药剂量,ASRA/ESRA建议旨在减少临床实践中局麻药剂量的大幅变异。
研究设计与样本
- 由ASRA和ESRA代表组成联合委员会实践建议小组,基于系统文献检索制定循证建议,无文献时采用专家意见。
主要发现
- 新生儿和/或婴儿脊麻布比卡因剂量为1 mg/kg,大于1岁儿童为0.5 mg/kg。
- 0.5%丁卡因推荐用于脊麻,剂量为0.07-0.13 mL/kg。
- 儿童超声引导上肢外周神经阻滞(如腋路、锁骨下、肌间沟、锁骨上)可安全使用布比卡因或罗哌卡因0.5-1.5 mg/kg。
- 右美托咪定可作为佐剂延长儿童外周神经阻滞持续时间。
关键数值与推荐
- 新生儿和/或婴儿脊麻布比卡因剂量1 mg/kg,大于1岁儿童0.5 mg/kg。
- 0.5%丁卡因脊麻剂量0.07-0.13 mL/kg。
- 超声引导上肢外周神经阻滞布比卡因或罗哌卡因剂量0.5-1.5 mg/kg。
- 右美托咪定可作佐剂延长儿童外周神经阻滞持续时间。
临床怎么用
- 儿童脊麻可参照年龄选择布比卡因剂量:新生儿和婴儿1 mg/kg,大于1岁0.5 mg/kg。
- 儿童超声引导上肢外周神经阻滞可使用布比卡因或罗哌卡因0.5-1.5 mg/kg。
- 右美托咪定可考虑作为佐剂延长儿童外周神经阻滞时间。
局限性
- 尚无高级别证据指导儿童区域阻滞局麻药剂量,部分建议基于专家意见。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Dosage of local anesthetics (LAs) used for regional anesthesia in children is not well determined. In order to evaluate and come to a consensus regarding some of these controversial topics, The European Society of Regional Anaesthesia and Pain Therapy (ESRA) and the American Society of Regional Anesthesia and Pain Medicine (ASRA) developed a Joint Committee Practice Advisory on Local Anesthetics and Adjuvants Dosage in Pediatric Regional Anesthesia. METHODS: Representatives from both ASRA and ESRA composed the joint committee practice advisory. Evidence-based recommendations were based on a systematic search of the literature. In cases where no literature was available, expert opinion was elicited. RESULTS: Spinal anesthesia with bupivacaine can be performed with a dose of 1 mg/kg for newborn and/or infant and a dose of 0.5 mg/kg in older children (>1 year of age). Tetracaine 0.5% is recommended for spinal anesthesia (dose, 0.07-0.13 mL/kg). Ultrasound-guided upper-extremity peripheral nerve blocks (eg, axillary, infraclavicular, interscalene, supraclavicular) in children can be performed successfully and safely using a recommended LA dose of bupivacaine or ropivacaine of 0.5 to 1.5 mg/kg. Dexmedetomidine can be used as an adjunct to prolong the duration of peripheral nerve blocks in children. CONCLUSIONS: High-level evidence is not yet available to guide dosage of LA used in regional blocks in children. The ASRA/ESRA recommendations intend to provide guidance in order to reduce the large variability of LA dosage currently observed in clinical practice.
引用
- Suresh S, Ecoffey C, Bosenberg A, et al. The European Society of Regional Anaesthesia and Pain Therapy/American Society of Regional Anesthesia and Pain Medicine Recommendations on Local Anesthetics and Adjuvants Dosage in Pediatric Regional Anesthesia. Reg Anesth Pain Med. 2018. PMID: 29319604. doi:10.1097/AAP.0000000000000702
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。